CAMBRIDGE, Mass., March 2, 2016 /CNW/ — Spero Therapeutics, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, today announced the appointment of Cristina Larkin as Chief Commercial Officer.

In her new post, which reports directly…